Status: current, Defined. Date: 31-Oct 2010. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3016991000168114 | Prohance 4.19 g/15 mL injection, 10 x 15 mL vials | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 3017001000168119 | Prohance (gadoteridol 4.19 g / 15 mL) injection, 10 x 15 mL vials (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 935868011000036116 | Prohance 4.19 g/15 mL injection solution, 10 x 15 mL vials | en | Synonym | Inactive | Case sensitive | Australian Medicines Terminology module |
| 935869011000036112 | Prohance (gadoteridol 4.19 g / 15 mL) injection solution, 10 x 15 mL vials (trade product pack) | en | Fully specified name | Inactive | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Prohance 4.19 g/15 mL injection, 10 x 15 mL vials | Is a | trade product pack | true | Inferred relationship | Some | ||
| Prohance 4.19 g/15 mL injection, 10 x 15 mL vials | Is a | gadoteridol 4.19 g/15 mL injection, 10 x 15 mL vials | true | Inferred relationship | Some | ||
| Prohance 4.19 g/15 mL injection, 10 x 15 mL vials | has TPUU | Prohance 4.19 g/15 mL injection, 15 mL vial | true | Inferred relationship | Some | 1 | |
| Prohance 4.19 g/15 mL injection, 10 x 15 mL vials | has TP | Prohance | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Prohance 4.19 g/15 mL injection, 10 x 15 mL vials | Is a | True | Prohance 4.19 g/15 mL injection, 10 x 15 mL vials | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR